Thyroid Hormone Action
甲状腺激素作用
基本信息
- 批准号:7574689
- 负责人:
- 金额:$ 2.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-09-30 至 2009-01-31
- 项目状态:已结题
- 来源:
- 关键词:3-iodothyronamineAffinityAgonistAmino AcidsAnimalsAromatic Amino AcidsBindingBiogenic AminesBiological AssayBiological PreservationBiologyBody TemperatureBrainCardiacCardiac OutputCatecholaminesChemicalsCongenital AbnormalityCouplingDataDecarboxylationDevelopmentDopamineDoseDropsEndocrinologyEnzymatic BiochemistryEnzymesEquilibriumEssential Amino AcidsFamilyFeverG-Protein-Coupled ReceptorsGTP-Binding ProteinsGenesGenetic TranscriptionHeartHomeostasisHormone ResponsiveHormonesHourHyperthyroidismLigandsMalignant NeoplasmsMediatingMembraneMetabolic DiseasesModificationMolecularMusNuclearNuclear ReceptorsNumbersPathway interactionsPhysiologicalPreparationProcessRangeRattusReceptor ActivationRegulationResearchResearch PersonnelRodentSerotoninSignal PathwaySignal TransductionStructureTarsThyroid GlandThyroid Hormone ReceptorThyroid HormonesThyroxineTissuesTranscriptional RegulationUpper armWorkdaydeiodinationdesignhemodynamicshuman GPRC5C proteinhuman diseasehyperthermia treatmentin vivoinduced hypothermianatural hypothermianon-genomicnovelprogramsreceptorresearch studyresponsethyronamine
项目摘要
The long-term objective of this project is to understand the molecular mechanisms of thyroid hormone action.
Thyroid hormone is an important regulator of development and homeostasis, and abnormalities in thyroid
status correlate with many human diseases ranging from cancer to birth defects to metabolic disorders.
Thyroxine (T4) is the major form of thyroid hormone that is secreted from the thyroid gland, and T4 is
metabolized to the active hormone T3 by enzymatic deiodination. T3 regulates the transcription of thyroid
hormone responsive genes by binding to and activating nuclear thyroid hormone receptors. However, there
are many effects of thyroid hormone that occur much faster than the timescale of transcriptional regulation,
and the molecular mechanisms of these rapid effects are unknown. This research plan is constructed around
the hypothesis that rapid thyroid hormone signaling involves a novel metabolite of T4 that is chemically
distinct from T3. This hypothesis is supported by experiments showing the existence of this novel metabolite
in tissue, as well as the induction of rapid physiological responses when the metabolite is administered in
vivo. In addition, this T4 metabolite is a potent agonist of a newly discovered orphan G protein-coupled
receptor (GPCR) related to the family of a biogenic amine GPCRs. This research plan seeks to further
explore this novel pathway of thyroid hormone signaling. Specific aim 1 involves chemical modification of
the metabolite to delineate the structural features important to GPCR activation. Specific aim 2 is a study to
understand the enzymology responsible for generating the rapid-acting T4 metabolite. Specific aim 3
involves the isolation, expression, and pharmacological characterization of the different subtypes of the
GPCR that responds to the metabolite. Specific aim 4 is an approach to examine different tissues for the
presence of the metabolite and perform quantitative analysis. Specific aim 5 is a plan to develop a chemical
antagonist of the metabolite that will be useful for studying the in vivo biology of this new thyroid hormone
signaling pathway.
该项目的长期目标是了解甲状腺激素作用的分子机制。
甲状腺激素是发育和体内平衡的重要调节剂,甲状腺异常
状态与许多人类疾病相关,从癌症到出生缺陷再到代谢紊乱。
甲状腺素(T4)是甲状腺分泌的甲状腺激素的主要形式,T4是
通过酶促脱碘代谢为活性激素 T3。 T3 调节甲状腺转录
通过结合并激活核甲状腺激素受体来调节激素反应基因。然而,有
甲状腺激素的许多作用发生得比转录调节的时间尺度快得多,
这些快速作用的分子机制尚不清楚。本研究计划围绕
假设快速甲状腺激素信号传导涉及 T4 的一种新型代谢物,该代谢物的化学性质是
与T3不同。这一假设得到了表明这种新型代谢物存在的实验的支持
在组织中,以及当代谢物施用在组织中时诱导快速的生理反应
体内。此外,这种 T4 代谢物是新发现的孤儿 G 蛋白偶联的有效激动剂
受体(GPCR)与生物胺 GPCR 家族相关。该研究计划旨在进一步
探索甲状腺激素信号传导的这一新途径。具体目标 1 涉及化学修饰
代谢物来描绘对 GPCR 激活重要的结构特征。具体目标 2 是一项研究
了解负责产生速效 T4 代谢物的酶学。具体目标3
涉及不同亚型的分离、表达和药理学特征
对代谢物做出反应的 GPCR。具体目标 4 是一种检查不同组织的方法
代谢物的存在并进行定量分析。具体目标 5 是开发化学品的计划
代谢物的拮抗剂,可用于研究这种新甲状腺激素的体内生物学
信号通路。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THOMAS Sterling SCANLAN其他文献
THOMAS Sterling SCANLAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THOMAS Sterling SCANLAN', 18)}}的其他基金
Chemical Biology Studies of 3-Iodothyronamine and Related Thyroid Hormone Metabol
3-碘甲腺胺及相关甲状腺激素代谢的化学生物学研究
- 批准号:
8235583 - 财政年份:2012
- 资助金额:
$ 2.25万 - 项目类别:
Chemical Biology Studies of 3-Iodothyronamine and Related Thyroid Hormone Metabol
3-碘甲腺胺及相关甲状腺激素代谢的化学生物学研究
- 批准号:
8464697 - 财政年份:2012
- 资助金额:
$ 2.25万 - 项目类别:
Chemical Biology Studies of 3-Iodothyronamine and Related Thyroid Hormone Metabol
3-碘甲腺胺及相关甲状腺激素代谢的化学生物学研究
- 批准号:
8665414 - 财政年份:2012
- 资助金额:
$ 2.25万 - 项目类别:
相似海外基金
Discovery of a High Affinity, Selective and β-arrestin Biased 5-HT7R Agonist
发现高亲和力、选择性和β-抑制蛋白偏向的 5-HT7R 激动剂
- 批准号:
10412227 - 财政年份:2022
- 资助金额:
$ 2.25万 - 项目类别:
Discovery of a High Affinity, Selective and β-arrestin Biased 5-HT7R Agonist
发现高亲和力、选择性和β-抑制蛋白偏向的 5-HT7R 激动剂
- 批准号:
10610473 - 财政年份:2022
- 资助金额:
$ 2.25万 - 项目类别:
Supplement to Discovery of a high affinity, selective and beta-arrestinbiased 5-HT7R Agonist Grant
对高亲和力、选择性和 β 抑制偏向 5-HT7R 激动剂发现的补充补助金
- 批准号:
10799162 - 财政年份:2022
- 资助金额:
$ 2.25万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6639179 - 财政年份:2001
- 资助金额:
$ 2.25万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6724797 - 财政年份:2001
- 资助金额:
$ 2.25万 - 项目类别:
General Anesthetics and nAcCHOR Agonist Affinity
全身麻醉药和 nAcCHOR 激动剂亲和力
- 批准号:
6636512 - 财政年份:2001
- 资助金额:
$ 2.25万 - 项目类别:
General Anesthetics and nAcCHOR Agonist Affinity
全身麻醉药和 nAcCHOR 激动剂亲和力
- 批准号:
6326889 - 财政年份:2001
- 资助金额:
$ 2.25万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6266928 - 财政年份:2001
- 资助金额:
$ 2.25万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6539099 - 财政年份:2001
- 资助金额:
$ 2.25万 - 项目类别:
General Anesthetics and nAcCHOR Agonist Affinity
全身麻醉药和 nAcCHOR 激动剂亲和力
- 批准号:
6520329 - 财政年份:2001
- 资助金额:
$ 2.25万 - 项目类别: